IRCT20171030037093N37 IRCT 2020-05-04 Esfahan University of Medical Sciences Lycopene nephroprotective effect in patients receiving vancomycin Evaluation of the nephroprotective effect of lycopene in patients receiving vancomycin 2020-04-28 anticipated 60 Complete https://irct.ir/trial/46859 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Since the total sample size is 60 people, 15 blocks of 4 were defined and 6 different modes of blocks were considered. Then, by determining random numbers by computer, the order of blocks was determined and finally the process of sampling was based on the obtained sequences, Blinding description: In order to blind, none of the patients and the outcome assessor were aware of the type of group therapy received by the patients until the end of study. The treatment pills were in two groups as closed packs with codes A and B, which were assigned to group A packs containing code A and to group B packs with code B. 3 Vancomycin-induced nephrotoxicity. Intervention 1: Intervention group: For people in the case group, lycopene tablets 15 mg with vancomycin will be prescribed once a day. Intervention 2: Control group: For control group participants, placebo tablets 15 mg with vancomycin will be prescribed once a day. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is I will decide until finishing the study